Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wang, Jingjuan
Zhou, Li
Cui, Chunlei
Liu, Zhening
and
Lu, Jie
2017.
Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits.
BMC Psychiatry,
Vol. 17,
Issue. 1,
Schiavone, Stefania
and
Trabace, Luigia
2017.
Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.
Frontiers in Psychiatry,
Vol. 8,
Issue. ,
Phensy, Aarron
Duzdabanian, Hasmik E.
Brewer, Samantha
Panjabi, Anurag
Driskill, Christopher
Berz, Annuska
Peng, George
and
Kroener, Sven
2017.
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment.
Frontiers in Behavioral Neuroscience,
Vol. 11,
Issue. ,
Berk, Michael
and
Berk, Lesley
2017.
Cognition in psychiatric disorders: from models to management.
The Lancet Psychiatry,
Vol. 4,
Issue. 3,
p.
173.
Breier, Alan
Liffick, Emily
Hummer, Tom A.
Vohs, Jenifer L.
Yang, Ziyi
Mehdiyoun, Nicole F.
Visco, Andrew C.
Metzler, Emmalee
Zhang, Ying
and
Francis, Michael M.
2018.
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
Schizophrenia Research,
Vol. 199,
Issue. ,
p.
395.
Sepehrmanesh, Zahra
Heidary, Mahsa
Akasheh, Negar
Akbari, Hossein
and
Heidary, Mahshid
2018.
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 82,
Issue. ,
p.
289.
Vieta, Eduard
Berk, Michael
Schulze, Thomas G.
Carvalho, André F.
Suppes, Trisha
Calabrese, Joseph R.
Gao, Keming
Miskowiak, Kamilla W.
and
Grande, Iria
2018.
Bipolar disorders.
Nature Reviews Disease Primers,
Vol. 4,
Issue. 1,
Klauser, Paul
Xin, Lijing
Fournier, Margot
Griffa, Alessandra
Cleusix, Martine
Jenni, Raoul
Cuenod, Michel
Gruetter, Rolf
Hagmann, Patric
Conus, Philippe
Baumann, Philipp S.
and
Do, Kim Q.
2018.
N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial.
Translational Psychiatry,
Vol. 8,
Issue. 1,
Yang, Xue
Wang, Yong
Li, Qiyan
Zhong, Yaxian
Chen, Liangpei
Du, Yajun
He, Jing
Liao, Lvshuang
Xiong, Kun
Yi, Chun-xia
and
Yan, Jie
2018.
The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.
Frontiers in Molecular Neuroscience,
Vol. 11,
Issue. ,
Wasserthal, Sven
Kloss, Christian
Hurlemann, René
and
Schultz, Johannes
2018.
N-Acetylcystein: neue Option zur frühen Bekämpfung von Schizophrenie.
DNP - Der Neurologe & Psychiater,
Vol. 19,
Issue. 2,
p.
28.
Willborn, Robert J.
Hall, Colleen P.
and
Fuller, Matthew A.
2019.
Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia.
Mental Health Clinician,
Vol. 9,
Issue. 3,
p.
116.
Chang, Chun-Hung
Lane, Hsien-Yuan
Tseng, Ping-Tao
Chen, Shaw-Ji
Liu, Chieh-Yu
and
Lin, Chieh-Hsin
2019.
Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
Journal of Psychopharmacology,
Vol. 33,
Issue. 4,
p.
436.
Slattery, John
and
Frye, Richard Eugene
2019.
The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine.
p.
203.
Mullier, Emeline
Roine, Timo
Griffa, Alessandra
Xin, Lijing
Baumann, Philipp S
Klauser, Paul
Cleusix, Martine
Jenni, Raoul
Alemàn-Gómez, Yasser
Gruetter, Rolf
Conus, Philippe
Do, Kim Q
and
Hagmann, Patric
2019.
N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study.
International Journal of Neuropsychopharmacology,
Vol. 22,
Issue. 8,
p.
478.
Robertson, Oliver D.
Coronado, Nieves G.
Sethi, Rickinder
Berk, Michael
and
Dodd, Seetal
2019.
Putative neuroprotective pharmacotherapies to target the staged progression of mental illness.
Early Intervention in Psychiatry,
Vol. 13,
Issue. 5,
p.
1032.
Ghaderi, Amir
Bussu, Anna
Tsang, Catherine
and
Jafarnejad, Sadegh
2019.
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
European Journal of Clinical Pharmacology,
Vol. 75,
Issue. 3,
p.
289.
Knight, Matthew J.
Mills, Natalie T.
and
Baune, Bernhard T.
2019.
Contemporary methods of improving cognitive dysfunction in clinical depression.
Expert Review of Neurotherapeutics,
Vol. 19,
Issue. 5,
p.
431.
Puthumana, Joseph S.
and
Regenold, William T.
2019.
Glucose-6-phosphate dehydrogenase activity in bipolar disorder and schizophrenia: Relationship to mitochondrial impairment.
Journal of Psychiatric Research,
Vol. 112,
Issue. ,
p.
99.
Ikonne, Uzoma S
Vann, Philip H
Wong, Jessica M
Forster, Michael J
and
Sumien, Nathalie
2019.
Supplementation with N-Acetyl Cysteine Affects Motor and Cognitive Function in Young but Not Old Mice.
The Journal of Nutrition,
Vol. 149,
Issue. 3,
p.
463.
Das, Tushar Kanti
Javadzadeh, Alborz
Dey, Avyarthana
Sabesan, Priyadharshini
Théberge, Jean
Radua, Joaquim
and
Palaniyappan, Lena
2019.
Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 91,
Issue. ,
p.
94.